#nuclear medicine market
Text
lu 177 cancer treatment | NuclearMedicineTherapy
Discover the efficacy of Lu-177 in cancer treatment at NuclearMedicineTherapy. Explore the transformative potential and advancements in nuclear medicine, offering targeted solutions for various cancers.
Know more at:
0 notes
Text
Global Nuclear Medicine Market Size, Trends, Analysis, Growth, Share, Industry Forecast, 2023-2030
Global Nuclear Medicine Market
The Global Nuclear Medicine Market was valued at US$ 5.97 Bn in 2022 estimated to reach US$ 11.59 Bn by 2030, with a CAGR of 8.33% from 2023-2030.
In the field of medicine known as nuclear medicine, numerous ailments such as cancer, cardiac disease, and neurological problems are diagnosed and treated using radioactive materials called radiopharmaceuticals. High-tech cameras allow medical personnel to monitor the radioactive tracers' progress. Additionally, two essential imaging modalities in nuclear medicine are single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
Read More: https://qualiketresearch.com/reports-details/Global-Nuclear-Medicine-Market
Market Drivers
The availability of a strong product pipeline and supportive government programs to increase accessibility to nuclear medicine is anticipated to drive market growth in the coming years. Clinical trials are being conducted on several products, such as betalains, omburtamab, yttrium-90 microspheres, PNT2003, and 177Lu-PNT2002. The U.S. has a favorable reimbursement environment for radiopharmaceuticals is expected to stimulate market expansion.
In addition, therapy requirements for patients are growing improvements in disease diagnosis and therapy as well as the approval of novel nuclear medicine-based technologies. For instance, GE Healthcare announced in September 2021 the introduction of a unique scanner with a new automated workflow feature that delivers an excellent view of cardiac anatomy and pathology to aid physicians in selecting the best course of treatment for a patient.
Market Segmentation
The scope of the Global Nuclear Medicine Market covers segmentation based on Diagnostics, Therapeutics, Applications, and Region.
Based on Diagnostics, the market is segmented into Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
Based on Therapeutics, the market is classified into Alpha Emitters, Beta Emitters, and Brachytherapy.
Based on Applications, the market is bifurcated into Cardiology, Neurology, Oncology, and Other Applications.
Request A Sample: https://qualiketresearch.com/request-sample/Global-Nuclear-Medicine-Market/request-sample
Regional Analysis
The Global Nuclear Medicine Market is segmented into 5 main regions, namely, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The primary market for nuclear medicine is North America.
The United States' booming healthcare industry, rising cancer rates, rising geriatric population, rise in product launches driving up radioisotope usage, and increased initiatives and investments in cutting-edge healthcare solutions for cancer treatment are all expected to contribute to the market's expansion. In the United States, funding for cancer illness research and treatment is likewise rising. The National Centre for Health Statistics (NCHS) of the Centres for Disease Control & Prevention (CDC) has produced data that estimates cancer-related investments might reach up to USD 7,176 million in 2021.
Key Developments
The Department of Nuclear Medicine at PSG Hospitals in Coimbatore, which is outfitted with cutting-edge technology for diagnosing cancer and other disorders, was opened in April 2022 by Health Minister Ma. Subramanian.
A program enabling nuclear medicine facilities the chance to become designated and certified Centres of Excellence in Radiopharmaceutical Therapy was introduced by SNMMI in February 2022. Strict regulatory, training, certification, experience, and performance standards will be met by the centers, resulting in optimal patient selection and radiopharmaceutical therapy outcomes.
Key Players
Mallinckrodt plc., General Electric Co., Medtronic, plc. (Covidien, acquired by Medtronic), Bayer AG, Cardinal Health, Inc., Lantheus Medical Imaging, Inc., IBA Group, Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Advanced Accelerator Applications S.A.
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
About Us:
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.
QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.
QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.
Contact Us:
6060 N Central Expy #500 TX 75204, U.S.A
+1 214 660 5449
1201, City Avenue, Shankar Kalat Nagar,
Wakad, Pune 411057, Maharashtra, India
+91 9284752585
Sharjah Media City , Al Messaned, Sharjah, UAE.
+91 9284752585
0 notes
Text
Nuclear Medicine Market Segment Analysis By Product, Application, End-Use, Region And Forecast Till 2030: Grand View Research Inc.
San Francisco, 17 Nov 2023: The Report Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2023 – 2030
The global��nuclear medicine market size is expected to reach USD 22.3 billion by 2030, registering a CAGR of 11.8% over the…
View On WordPress
#Nuclear Medicine Industry#Nuclear Medicine Market#Nuclear Medicine Market 2023#Nuclear Medicine Market 2030#Nuclear Medicine Market Revenue#Nuclear Medicine Market Share#Nuclear Medicine Market Size
0 notes
Link
#adroit market research#nuclear medicine market#nuclear medicine market growth#nuclear medicine market value#nuclear medicine market size
0 notes
Text
Nuclear Medicine
"Unveiling a new dimension in cancer treatment! 🌌💥 Netaji Subhas Chandra Bose Cancer Hospital's cutting-edge Nuclear Medicine Department is harnessing the power of radioactive isotopes to combat cancer and manage its symptoms. 🛡️🔬 The future of imaging and precise diagnosis with the world-class PET-CT Scanner. 🌟🏥
0 notes
Text
#Nuclear Medicine Market#Nuclear Medicine Market size#Nuclear Medicine Market share#Nuclear Medicine Market trends#Nuclear Medicine Market analysis#Nuclear Medicine Market forecast#Nuclear Medicine Market outlook
1 note
·
View note
Link
#adroit market research#nuclear medicine market#nuclear medicine market growth#nuclear medicine market value#nuclear medicine market size
0 notes
Link
The growing demand for radioisotopes in cancer imaging is a major driver for the nuclear medicine market.
#adroit market research#nuclear medicine market#nuclear medicine market growth#nuclear medicine market value#nuclear medicine market size
0 notes
Link
The nuclear medicine market is projected to reach USD 18.10 billion by 2025 growing with CAGR of 10.1% during the forecast period.
#adroit market research#nuclear medicine market#nuclear medicine market growth#nuclear medicine market value#nuclear medicine market size
0 notes
Text
How do you determine whether PRRT is the treatment of choice for your condition? - Nuclear Medicine Therapy
In this video Dr. Ishita B. Sen, Head Of Department of Nuclear Medicine at Fortis Memorial Research Institute explains how to determine whether PRRT is the treatment of choice for your condition.
Know more at:
0 notes
Link
Rising number of procedures to diagnose and treat cancer is a key driver for the growth of nuclear medicine market globally.
0 notes
Link
Radioisotopes used in oncology application are expected to boost the nuclear medicine demand. In 2018, North America dominated the nuclear medicines market...
#adroit market research#nuclear medicine market#nuclear medicine market growth#nuclear medicine market value#nuclear medicine market size
0 notes
Text
My life my stones 💗
6 notes
·
View notes
Last Seen Blogs
super-alpine
Super Alpine
yaemikomine
‘cause you were never mine
charizardstolemynickname
i aint a nerd i promise
pleaseplayghosttrick
www.floralartflorists.co.uk
alotusinthepond-art
A Lotus in the pond.